Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression

BACKGROUND: Alzheimer’s disease (AD) is a neurodegenerative disorder, primarily affecting memory. That disorder is thought to be a consequence of neuronal network disturbances and synapse loss. Decline in cognitive function is associated with a high burden of neuropsychiatric symptoms (NPSs) such as...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Res Ther
Main Authors: Hesse, Raphael, Lausser, Ludwig, Gummert, Pauline, Schmid, Florian, Wahler, Anke, Schnack, Cathrin, Kroker, Katja S., Otto, Markus, Tumani, Hayrettin, Kestler, Hans A., Rosenbrock, Holger, von Arnim, Christine A. F.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343324/
https://ncbi.nlm.nih.gov/pubmed/28274265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-017-0245-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados